Also, an increase in miR-27a was found in purified CD4+ T cells of MS patients in the relapsing phase to promote the differentiation of T naïve cells to Th17 cells, probably influencing the transforming growth factor beta (TGF-β) signaling pathway [44]. Here, TGFB1 is linked to myeloid sarcoma.